Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Retained in naltrexone maintenance or abstinent | |||||
[41]
Systematic review |
30 people Data from 1 RCT |
Retained in naltrexone maintenance or abstinent
12 weeks
10/15 (67%) with antagonist-induced withdrawal 5/15 (33%) with tapered methadone |
RR 2.00 95 % CI 0.90 to 4.45 P = 0.09 |
Not significant | |
[41]
Systematic review |
240 people 3 RCTs in this analysis |
Retained in naltrexone maintenance or abstinent
12 weeks
26/122 (21%) with antagonist-induced withdrawal 9/118 (8%) with clonidine |
RR 2.77 95% CI 1.37 to 5.61 P = 0.004 |
Moderate effect size | antagonist-induced withdrawal |
[41]
Systematic review |
72 people Data from 1 RCT |
Retained in naltrexone maintenance or abstinent
12 weeks
7/35 (20%) with antagonist-induced withdrawal 9/37 (24%) with buprenorphine |
RR 0.82 95% CI 0.34 to 1.97 P = 0.66 |
Not significant |